Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDoric Nimrod 2 Regulatory News (DNA2)

  • There is currently no data for DNA2

Kepler Trust Intelligence: New Research

6 Feb 2020 14:00

RNS Number : 2279C
Doric Nimrod Air Two Limited
06 February 2020
 

Doric Nimrod Air Two: New research

06/02/2020

News and sentiment leaves the London-listed aircraft-leasing funds offering high prospective yields to investors...

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAAAKEAFEEFA
Date   Source Headline
21st Jan 20257:00 amRNSCancellation of Trading on the LSE
21st Jan 20257:00 amRNSCompletion of Compulsory Redemption of Shares
16th Jan 202512:06 pmRNSCompulsory Redemption of Shares
23rd Dec 20244:35 pmRNSHolding(s) in Company
12th Dec 20243:47 pmRNSUNAUDITED INTERIM FINANCIAL REPORT
5th Dec 20245:55 pmRNSResult of AGM
2nd Dec 20243:56 pmRNSASSET SALE UPDATE
18th Nov 20243:29 pmRNSNotice of AGM
11th Nov 202412:43 pmRNSASSET SALE UPDATE
5th Nov 20242:17 pmRNSUpdate – Anticipated Redemption of Shares
15th Oct 20244:44 pmRNSQuarterly Fctsheet
15th Oct 20244:42 pmRNSDividend Declaration
15th Oct 20247:00 amRNSAsset Sale Update
2nd Oct 20243:48 pmRNSAsset Sale Update
2nd Sep 20245:26 pmRNSHolding(s) in Company
29th Aug 20243:49 pmRNSHolding(s) in Company
21st Aug 20247:00 amRNSSALE OF REMAINING FIVE ASSETS
24th Jul 20247:00 amRNSAnnual Financial Report
11th Jul 20244:05 pmRNSDividend Declaration
11th Jul 20244:05 pmRNSQuarterly Factsheet
11th Apr 20245:06 pmRNSQuarterly Factsheet
11th Apr 20245:04 pmRNSDividend Declaration
11th Jan 20244:19 pmRNSQuarterly Report
11th Jan 20244:18 pmRNSDividend Declaration
22nd Dec 202312:24 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSCOMPLETION PARTIAL COMPULSORY REDEMPTION & TVR
15th Dec 20232:43 pmRNSUnaudited Interim Financial Report
11th Dec 20237:00 amRNSPartial Compulsory Redemption of Shares
8th Dec 20237:00 amRNSResult of AGM
13th Nov 20233:45 pmRNSNotice of AGM
10th Oct 20234:45 pmRNSQuarterly Report
10th Oct 20234:44 pmRNSDividend Declaration
9th Oct 20237:00 amRNSSALE OF TWO ASSETS
31st Jul 20234:19 pmRNSResignation of a non-executive director
24th Jul 20235:41 pmRNSAnnual Financial Report
13th Jul 20234:57 pmRNSQuarterly Report
13th Jul 20234:57 pmRNSDividend Declaration
18th Apr 20237:00 amRNSDirectorate Change
13th Apr 20235:03 pmRNSQuarterly Report
13th Apr 20235:02 pmRNSDividend Declaration
6th Apr 20235:14 pmRNSMSN 110 REDELIVERY CONDITION
4th Apr 20237:00 amRNSDirectorate Change
14th Mar 202312:56 pmRNSMSN109 REDELIVERY CONDITION
16th Feb 20232:11 pmRNSMSN105, MSN106 and MSN107 Redelivery Condition
15th Feb 20237:00 amRNSChange in Board and Board Committee Composition
13th Jan 20234:58 pmRNSQuarterly Report
12th Jan 20235:19 pmRNSDividend Declaration
15th Dec 20225:24 pmRNSHalf-year Report
13th Dec 20229:34 amRNSDirector Declaration
12th Dec 202212:08 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.